What does this research mean for the field?

Nutrition is a primary, disease-modifying component of care in Paediatric Inflammatory Bowel Disease, requiring individualized dietary therapies and comprehensive monitoring to manage malnutrition and support growth. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To review clinical evidence and practical strategies for nutritional assessment, monitoring, and therapeutic dietary interventions in paediatric inflammatory bowel disease.

August 28, 2026NutrientsOpen Access

Nutritional Monitoring and Intervention in Paediatric Inflammatory Bowel Disease

View Full Paper

Ask AI

Bookmark

Authors

LALauren Arpe LJLucy Jackman KJKelsey Jones

Discussion

Member takes

Overview

Narrative review highlights dietary therapies and nutritional monitoring in paediatric inflammatory bowel disease, indicating food-based strategies support remission while preserving quality of life.

Key Points

To review clinical evidence and practical strategies for nutritional assessment, monitoring, and therapeutic dietary interventions in paediatric inflammatory bowel disease.
Synthesized current clinical evidence and management guidelines regarding malnutrition, growth faltering, and micronutrient monitoring in paediatric inflammatory bowel disease.
Evaluated primary nutritional therapies, including exclusive enteral nutrition, the Crohn's Disease Exclusion Diet, partial enteral nutrition, and maintenance dietary regimens.
Exclusive Enteral Nutrition (EEN) serves as first-line induction therapy for mild-to-moderate Crohn's disease, achieving clinical remission in 60% to 80% of paediatric patients.
Whole-food options like the Crohn's Disease Exclusion Diet combined with partial enteral nutrition achieve induction remission rates comparable to exclusive enteral nutrition while improving patient adherence.
Active systemic inflammation complicates biochemical nutritional markers, necessitating combined clinical, dietary, and laboratory monitoring to prevent growth faltering and bone accrual deficits.

Cite This Study

Arpe et al. (2026) studied this question.

synapsesocial.com/papers/6a914631d15324a1df3a9a73 https://doi.org/10.3390/nu18172786

View Full Paper

Ask AI

Bookmark

August 28, 2026NutrientsOpen Access

Nutritional Monitoring and Intervention in Paediatric Inflammatory Bowel Disease

View Full Paper

Ask AI

Bookmark

Authors

LALauren Arpe LJLucy Jackman KJKelsey Jones

Discussion

Member takes

Overview

Narrative review highlights dietary therapies and nutritional monitoring in paediatric inflammatory bowel disease, indicating food-based strategies support remission while preserving quality of life.

Key Points

To review clinical evidence and practical strategies for nutritional assessment, monitoring, and therapeutic dietary interventions in paediatric inflammatory bowel disease.
Synthesized current clinical evidence and management guidelines regarding malnutrition, growth faltering, and micronutrient monitoring in paediatric inflammatory bowel disease.
Evaluated primary nutritional therapies, including exclusive enteral nutrition, the Crohn's Disease Exclusion Diet, partial enteral nutrition, and maintenance dietary regimens.
Exclusive Enteral Nutrition (EEN) serves as first-line induction therapy for mild-to-moderate Crohn's disease, achieving clinical remission in 60% to 80% of paediatric patients.
Whole-food options like the Crohn's Disease Exclusion Diet combined with partial enteral nutrition achieve induction remission rates comparable to exclusive enteral nutrition while improving patient adherence.
Active systemic inflammation complicates biochemical nutritional markers, necessitating combined clinical, dietary, and laboratory monitoring to prevent growth faltering and bone accrual deficits.

Cite This Study

Arpe et al. (2026) studied this question.

synapsesocial.com/papers/6a914631d15324a1df3a9a73 https://doi.org/10.3390/nu18172786

View Full Paper

Ask AI

Bookmark